cas 2458219-89-9|| where to buy (2S,4R)-1-[(2S)-2-(5-aminopentanoylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methylthiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide;hydrochloride

Nombre del producto:(2S,4R)-1-[(2S)-2-(5-aminopentanoylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methylthiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide;hydrochloride

IUPAC Name:(2S,4R)-1-[(2S)-2-(5-aminopentanamido)-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide hydrochloride

: CAS：2458219-89-9; Fórmula molecular：C28H42ClN5O4S; Pureza：95%

: Número de catálogo：CM1076691; Peso molecular：580.19

Unidad de embalaje	Stock disponible	Precio($)
CM1076691-100mg	in stock	ȌǆȌ
CM1076691-250mg	in stock	ǲȌǆ
CM1076691-500mg	in stock	ƼȷƋ
CM1076691-1g	in stock	ȷȌȦȌ

Consulta: sales@chemenu.com

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2458219-89-9 regularly via the above email.

Notas adicionales

Verification code*

refresh

Detalles del producto

: Núm. De CAS :2458219-89-9; Fórmula molecular:C28H42ClN5O4S; Punto de fusión:-; Código de sonrisas:Cl.C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CCCCN)C(C)(C)C)C1=CC=C(C=C1)C1=C(C)N=CS1; Densidad:

: Número de catálogo:CM1076691; Peso molecular:580.19; Punto de ebullición:; Nº Mdl:; Almacenamiento:

Category Infos

: PROTAC-E3 Ligase Ligands; Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.; PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Formulario de consulta

Detalles del producto

Category Infos

Related Products